Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Color-Coded triage: a quick way to spot sick kids?

NCT ID NCT07739004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study looks at whether the color-coded triage system (Red, Yellow, Green) used in Turkish emergency departments can accurately predict which children with fever will become seriously ill. Researchers will track 3,000 children aged 0-18 who come to the emergency room with a fever, recording their vital signs and triage category. The goal is to see if the initial triage assessment and physiological measurements can identify those at risk for complications like ICU admission or severe infection.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Turkish Ministry of Health three-level color-coded triage system (Red-Yellow-Green)
What this could lead to
If the triage system proves accurate, it could help emergency doctors quickly identify which children with fever need intensive care, potentially saving lives.
What could go wrong
This is an observational study, so it can only show associations, not cause and effect. The triage system may not perform consistently across different hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive children aged 0-18 years presenting with fever to the participating pediatric emergency departments during the study period.

Ages

0 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 0-18 years * Presentation to the pediatric emergency department * Fever \>=38.0 C at triage OR history of fever within the preceding 24 hours Exclusion Criteria: * Presentation due to trauma * Elective visits * Missing triage data * Re-attendance within 72 hours for the same episode (only the first visit is included)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fever are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adana City Training and Research Hospital

    RECRUITING

    Adana, Turkey (Türkiye)

  • Akdeniz University Faculty of Medicine

    RECRUITING

    Antalya, Turkey (Türkiye)

  • Celal Bayar University Faculty of Medicine

    RECRUITING

    Manisa, Turkey (Türkiye)

  • Cukurova University Faculty of Medicine

    RECRUITING

    Adana, Turkey (Türkiye)

  • Dokuz Eylul University Faculty of Medicine

    RECRUITING

    Izmir, Turkey (Türkiye)

  • Erciyes University Faculty of Medicine

    RECRUITING

    Kayseri, Talas, 38039, Turkey (Türkiye)

  • Kartal Dr. Lutfi Kirdar City Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • Kayseri City Hospital

    RECRUITING

    Kayseri, Turkey (Türkiye)

  • Osmangazi University Faculty of Medicine

    RECRUITING

    Eskişehir, Turkey (Türkiye)

  • Tokat University Faculty of Medicine

    RECRUITING

    Tokat Province, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.